These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 36856762)
41. Expression of delta F508 cystic fibrosis transmembrane conductance regulator protein and related chloride transport properties in the gallbladder epithelium from cystic fibrosis patients. Dray-Charier N; Paul A; Scoazec JY; Veissière D; Mergey M; Capeau J; Soubrane O; Housset C Hepatology; 1999 Jun; 29(6):1624-34. PubMed ID: 10347100 [TBL] [Abstract][Full Text] [Related]
42. The cystic fibrosis transmembrane regulator (CFTR) in the kidney. Morales MM; Falkenstein D; Lopes AG An Acad Bras Cienc; 2000 Sep; 72(3):399-406. PubMed ID: 11028104 [TBL] [Abstract][Full Text] [Related]
47. Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations. Harutyunyan M; Huang Y; Mun KS; Yang F; Arora K; Naren AP Am J Physiol Lung Cell Mol Physiol; 2018 Apr; 314(4):L529-L543. PubMed ID: 29351449 [TBL] [Abstract][Full Text] [Related]
48. Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation. Meng X; Wang Y; Wang X; Wrennall JA; Rimington TL; Li H; Cai Z; Ford RC; Sheppard DN J Biol Chem; 2017 Mar; 292(9):3706-3719. PubMed ID: 28087700 [TBL] [Abstract][Full Text] [Related]
49. Cystic Fibrosis Transmembrane Conductance Regulator: Roles in Chronic Obstructive Pulmonary Disease. Dransfield M; Rowe S; Vogelmeier CF; Wedzicha J; Criner GJ; Han MK; Martinez FJ; Calverley P Am J Respir Crit Care Med; 2022 Mar; 205(6):631-640. PubMed ID: 34982651 [TBL] [Abstract][Full Text] [Related]
51. A new era for people with cystic fibrosis. Bierlaagh MC; Muilwijk D; Beekman JM; van der Ent CK Eur J Pediatr; 2021 Sep; 180(9):2731-2739. PubMed ID: 34213646 [TBL] [Abstract][Full Text] [Related]
52. Cystic fibrosis transmembrane conductance regulator-modifying medications: the future of cystic fibrosis treatment. Pettit RS Ann Pharmacother; 2012; 46(7-8):1065-75. PubMed ID: 22739718 [TBL] [Abstract][Full Text] [Related]
53. Mutating the Conserved Q-loop Glutamine 1291 Selectively Disrupts Adenylate Kinase-dependent Channel Gating of the ATP-binding Cassette (ABC) Adenylate Kinase Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Reduces Channel Function in Primary Human Airway Epithelia. Dong Q; Ernst SE; Ostedgaard LS; Shah VS; Ver Heul AR; Welsh MJ; Randak CO J Biol Chem; 2015 May; 290(22):14140-53. PubMed ID: 25887396 [TBL] [Abstract][Full Text] [Related]
55. On the mechanism of gating defects caused by the R117H mutation in cystic fibrosis transmembrane conductance regulator. Yu YC; Sohma Y; Hwang TC J Physiol; 2016 Jun; 594(12):3227-44. PubMed ID: 26846474 [TBL] [Abstract][Full Text] [Related]
56. Treatment of Pulmonary Disease of Cystic Fibrosis: A Comprehensive Review. Girón Moreno RM; García-Clemente M; Diab-Cáceres L; Martínez-Vergara A; Martínez-García MÁ; Gómez-Punter RM Antibiotics (Basel); 2021 Apr; 10(5):. PubMed ID: 33922413 [TBL] [Abstract][Full Text] [Related]
57. What's new in cystic fibrosis? From treating symptoms to correction of the basic defect. Proesmans M; Vermeulen F; De Boeck K Eur J Pediatr; 2008 Aug; 167(8):839-49. PubMed ID: 18389279 [TBL] [Abstract][Full Text] [Related]
58. Impact of highly effective CFTR modulator therapy on digital clubbing in patients with cystic fibrosis. Mahlen T; Barton L; Roberts D J Cyst Fibros; 2022 Sep; 21(5):861-865. PubMed ID: 35915048 [TBL] [Abstract][Full Text] [Related]
59. Effectiveness and Safety of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Children With Cystic Fibrosis: A Meta-Analysis. Li Q; Liu S; Ma X; Yu J Front Pediatr; 2022; 10():937250. PubMed ID: 35844763 [TBL] [Abstract][Full Text] [Related]